ストックスクリーナーアプリを入手
72.80
2.12%
1.51
プレマーケット:
73.14
0.34
+0.47%
前日終値:
$71.29
開ける：
$71
24時間の取引高:
8.53M
Relative Volume:
1.01
時価総額：
$92.62B
収益：
$402.11B
当期純損益:
$1.73B
株価収益率:
52.62
EPS:
1.3835
ネットキャッシュフロー:
$7.81B
1週間 パフォーマンス:
-2.69%
1か月 パフォーマンス:
-1.86%
6か月 パフォーマンス:
-4.69%
1年 パフォーマンス:
+7.74%
1日の値動き範囲:
$70.25
$73.28
1週間の範囲:
$70.21
$74.47
52週間の値動き範囲:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Compare CVS vs UNH, CI, ELV, HUM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
72.80 | 92.62B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
272.28 | 247.14B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
265.87 | 70.10B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
290.33 | 64.08B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
172.23 | 20.68B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | 開始されました | Goldman | Buy |
| 2025-08-18 | アップグレード | UBS | Neutral → Buy |
| 2025-08-14 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy |
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2023-12-22 | 開始されました | HSBC Securities | Buy |
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-05-26 | 開始されました | Piper Sandler | Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Buy |
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 開始されました | Goldman | Buy |
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-17 | 開始されました | Piper Sandler | Overweight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy |
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-13 | 開始されました | Bernstein | Outperform |
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-18 | 開始されました | Barclays | Overweight |
| 2018-11-29 | 再開されました | Goldman | Neutral |
| 2018-11-28 | 開始されました | Evercore ISI | Outperform |
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform |
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-13 | 繰り返されました | Citigroup | Neutral |
すべてを表示
Cvs Health Corp (CVS) 最新ニュース
CVS Health (CVS) Strengthens Market Position Amid Analyst Confidence and Industry Shifts - Insider Monkey
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note - Yahoo! Finance Canada
CVS Reaches Proposed Settlement with FTC, Easing Uncertainty - GuruFocus
FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access - statnews.com
CVS Health stock holds at Outperform as Leerink sees FTC settlement progress - Investing.com
CVS Reaches Proposed Settlement With FTC Over Insulin Pricing - GuruFocus
CVS Nearing FTC Settlement Overlawsuit, JPMorgan Analyst Notes - GuruFocus
CVS reaches insulin pricing settlement with FTC - Reuters
CVS Health MinuteClinic Services Expand Access to Affordable Primary Care Across US in 2026 - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - GuruFocus
CVS Health's Aetna gives $35K to community orgs in Missouri - Drug Store News
Bernstein Upgrades CVS Health (CVS) Stock to Outperform from Market Perform - Insider Monkey
CVS Stock Quote Price and Forecast - CNN
CVS Health Corp. stock under valuation scrutiny after governance overhaul signals cash flow pressure - AD HOC NEWS
CVS (CVS) director John Gallina granted 582 shares as semi-annual retainer - Stock Titan
CVS Health Corp. Hits Day Low of $71.60 Amid Price Pressure - Markets Mojo
Best Healthcare Stocks to Buy After the Market Pullback - Yahoo Finance
Best Healthcare Stocks to Buy After the Market Pullback - The Motley Fool
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
John E. Gallina becomes CVS Health (CVS) reporting director on Form 3 - Stock Titan
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
CVS Health appoints John E. Gallina to board of directors and audit committee - Investing.com
CVS, Caremark Pocket Money Meant For Rebates, Suit Claims - Law360
CVS Health adds John E. Gallina to board, names him Audit Committee financial expert - TradingView
Former Elevance CFO John Gallina joins CVS Health (CVS) board and audit committee - Stock Titan
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Lawsuit: CVS Caremark inflated drug costs via ‘manipulation scheme’ - InsuranceNewsNet
CVS Declares Consistent Quarterly Dividend Amid Legal Settlement - GuruFocus
CVS Health sets May 4 payout for 66.5-cent quarterly dividend - Stock Titan
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
CVS Health may have violated antitrust laws, Republican lawmakers say - MSN
CVS Health Foundation Invests $2.24 Million to Strengthen Community Health in Charlotte's Historic West End - Finviz
CVS Pharmacy's New AI-Driven Health Screening Expands Access Nationwide Amid Rising Chronic Disease - AD HOC NEWS
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS Remains in Turnaround Mode, Shooting for Ambitious Targets Through 2028 - Morningstar
CVS Health Corporation $CVS Shares Purchased by National Bank of Canada FI - MarketBeat
Moore Capital Management LP Sells 50,000 Shares of CVS Health Corporation $CVS - MarketBeat
Elevation Point Wealth Partners LLC Increases Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Best Health Insurance Stocks for 2026 and How to Invest - The Motley Fool
Iron Triangle Partners LP Has $60.15 Million Stake in CVS Health Corporation $CVS - MarketBeat
KKM Financial LLC Grows Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Stock Holdings Reduced by Holocene Advisors LP - MarketBeat
150,000 Shares in CVS Health Corporation $CVS Acquired by Capitolis Liquid Global Markets LLC - MarketBeat
Chevy Chase Trust Holdings LLC Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
California Public Employees Retirement System Has $175.91 Million Stake in CVS Health Corporation $CVS - MarketBeat
Bank of Nova Scotia Has $68.82 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp Stock (ISIN: US1266501006) Eyes Recovery Amid Analyst Upgrades and Solid FY26 Guidan - AD HOC NEWS
CVS Health Q4 Earnings Beat Expectations but Unchanged 2026 Guidance Tempers Optimism - AD HOC NEWS
Seniors Overpaid Medicare Premiums By $13.4B In 2025. That's About $212 For Every Enrollee, Joint Economic Committee EstimatesCVS Health (NYSE:CVS), UnitedHealth Group (NYSE:UNH) - Benzinga
CVS Health Corporation $CVS Shares Bought by Calydon Capital - MarketBeat
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
1.68%
大文字化:
|
ボリューム (24 時間):